Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
NCT05913674Phase 2Recruiting
- Start
- May 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil in peritoneal carcinomatosis (PC), appendiceal neoplasms, colorectal cancer (CRC). Started May 2026; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
peritoneal carcinomatosis (PC)appendiceal neoplasmscolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05913674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05913674.